Literature DB >> 7513027

Design and synthesis of RNA-specific groove-binding cations: implications for antiviral drug design.

A W McConnaughie1, J Spychala, M Zhao, D Boykin, W D Wilson.   

Abstract

As as initial step in the design of structure-specific RNA-interactive molecules as potential antiviral agents, we have focused on the synthesis of molecules that exhibit strong and preferential binding to duplex RNA. A series of polycationic ligands have been synthesized, and the degree of preferential binding to RNA has initially been determined by thermal denaturation (delta Tm) with both RNA [poly(A).poly(U)] and DNA [poly(dA).poly(dT)] polymers at a variety of pH values. Seven compounds from the series exhibit a substantial degree of RNA-selective binding. The relatively high delta Tm values obtained suggest a specific mode of interaction between these ligands and the RNA helix. By contrast, the much lower delta Tm values with poly(dA).poly(dT) DNA reflect a more nonspecific interaction mode. A viscometric titration study with poly(A).poly(U) confirms that they do not bind by intercalation. The results, combined with the known structure and electronegative potential of duplex RNA, suggest that these molecules bind in the major groove via specific electrostatic and/or hydrogen-bonded interactions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513027     DOI: 10.1021/jm00034a004

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  The binding mode of drugs to the TAR RNA of HIV-1 studied by electric linear dichroism.

Authors:  C Bailly; P Colson; C Houssier; F Hamy
Journal:  Nucleic Acids Res       Date:  1996-04-15       Impact factor: 16.971

2.  Synthesis of 3,3'-di-O-methyl ardimerin and exploration of its DNA binding properties.

Authors:  Miran Mavlan; Kevin Ng; Harmanpreet Panesar; Akop Yepremyan; Thomas G Minehan
Journal:  Org Lett       Date:  2014-04-09       Impact factor: 6.005

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.